These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12704879)

  • 1. Rectal cancer--clinical value of adjuvant and neoadjuvant treatment.
    Sjödahl R
    Kongressbd Dtsch Ges Chir Kongr; 2002; 119():149-52. PubMed ID: 12704879
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multimodal therapy of rectal carcinoma].
    Lehnert T; Herfarth C
    Chirurg; 1998 Apr; 69(4):384-92. PubMed ID: 9612620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant radiochemotherapy for rectal cancer].
    Zehentmayr F; Wolf M; Weissenborn Y; Feldmann HJ; Belka C
    MMW Fortschr Med; 2011 Sep; 153(35):31-3. PubMed ID: 21916302
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery.
    Klos CL; Bordeianou LG; Sylla P; Chang Y; Berger DL
    Dis Colon Rectum; 2011 Feb; 54(2):171-5. PubMed ID: 21228664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant and adjuvant radiochemotherapy for rectal carcinoma].
    Seegenschmiedt MH
    MMW Fortschr Med; 2007 Jun; 149(23):33-5. PubMed ID: 18062575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of (neo-)adjuvant therapy in rectal carcinoma].
    Ulrich A; Hartel M; Weitz J; Friess H; Büchler M
    Dtsch Med Wochenschr; 2004 Apr; 129(17):957-62. PubMed ID: 15083399
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of rectal cancer].
    Rödel C; Bruch HP; Hofheinz R; Lang H; Arnold D
    Onkologie; 2010; 33 Suppl 4():19-23. PubMed ID: 20431308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.
    Rich TA; Ota D; Rosenthal SA; Minsky BD; Bader JL; Coia LR; Janjan NA; John MJ; Merrick GS; Raben D; Tepper JE; Saltz L; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1473-80. PubMed ID: 11037560
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal staging and treatment of localised rectal cancer.
    Påhlman L
    Ann Oncol; 2002; 13 Suppl 4():251-5. PubMed ID: 12401698
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
    Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer?
    Petrelli NJ
    J Surg Oncol; 2003 Feb; 82(2):79-83. PubMed ID: 12561061
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative neo-adjuvant therapy for curable rectal cancer--reaching a consensus 2008.
    Scott NA; Susnerwala S; Gollins S; Myint AS; Levine E
    Colorectal Dis; 2009 Mar; 11(3):245-8. PubMed ID: 18637934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
    Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current neoadjuvant strategies in rectal cancer.
    Julien LA; Thorson AG
    J Surg Oncol; 2010 Mar; 101(4):321-6. PubMed ID: 20187066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery.
    Peng HH; Zhou XH; Zhou TC; Qiu XS; You KY
    Radiat Oncol; 2019 Jan; 14(1):8. PubMed ID: 30651116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical oncology issues in locally advanced rectal cancer.
    Ooi K; Gibbs P; Faragher I
    ANZ J Surg; 2011 Nov; 81(11):790-6. PubMed ID: 22295389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
    Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
    Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.